Dxterity Diagnostics
Rancho Dominquez, US · California corporation
Healthtech
Founders & leadership
RT
Robert TerbrueggenExecutive Officer, Director
JH
James HealyExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$797.4KraisedOct 2021 · 2 investors · OtherRule 506(b)
▶$797.4KraisedOct 2021 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ivan MijatovicDirector
- Gary BlackburnDirector
- James HealyExecutive Officer, Director
- Jamie PlattDirector
- Robert TerbrueggenExecutive Officer, Director
- Offering amount
- $797.4K
- Amount sold
- $797.4K
- First sale
- Aug 2018
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$2.8MraisedOct 2021 · 12 investors · OtherRule 506(b)
▶$2.8MraisedOct 2021 · 12 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Gary BlackburnDirector
- James HealyExecutive Officer, Director
- Robert TerbrueggenExecutive Officer, Director
- Ivan MijatovicDirector
- Jamie PlattDirector
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- First sale
- Aug 2020
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$163KraisedOct 2021 · 1 investors · OtherRule 506(b)
▶$163KraisedOct 2021 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Robert TerbrueggenExecutive Officer, Director
- Gary BlackburnDirector
- James HealyExecutive Officer, Director
- Jamie PlattDirector
- Ivan MijatovicDirector
- Offering amount
- $163K
- Amount sold
- $163K
- First sale
- Dec 2014
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$37.2KraisedOct 2021 · 1 investors · OtherRule 506(b)
▶$37.2KraisedOct 2021 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jamie PlattDirector
- James HealyExecutive Officer, Director
- Ivan MijatovicDirector
- Gary BlackburnDirector
- Robert TerbrueggenExecutive Officer, Director
- Offering amount
- $37.2K
- Amount sold
- $37.2K
- First sale
- Nov 2020
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$252KraisedOct 2021 · 1 investors · OtherRule 506(b)
▶$252KraisedOct 2021 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ivan MijatovicDirector
- Jamie PlattDirector
- James HealyExecutive Officer, Director
- Gary BlackburnDirector
- Robert TerbrueggenExecutive Officer, Director
- Offering amount
- $252K
- Amount sold
- $252K
- First sale
- Jun 2014
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$106.3KraisedAug 2021 · 8 investors · Other Health CareRule 506(b)
▶$106.3KraisedAug 2021 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James HealyExecutive Officer, Director
- Edward Allan LaurieDirector
- Robert Henry TerbrueggenExecutive Officer, Director, Promoter
- Offering amount
- $106.3K
- Amount sold
- $106.3K
- First sale
- Sep 2009
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$100KraisedJan 2015 · 1 investors · Other Health CareRule 506(b)
▶$100KraisedJan 2015 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert TerbrueggenExecutive Officer, Director
- James HealyExecutive Officer, Director
- Offering amount
- $100K
- Amount sold
- $100K
- Minimum investment
- $100K
- First sale
- Dec 2014
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $280K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $167K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.